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Abstract:    We  here  report  an  efficient  microwave-assisted  protocol  for  the  synthesis  of  new  arylimino-
thiazolylidene-2-thiazolidin-4-ones 6 and their azarhodacyanines derivatives 7 with quantitative yield from 2'-
(methylthio)-4'-oxo-3H,4'H-[2,5-bithiazolylidene]-3'-ium tosylates 5 and 2-arylimino-5-(thiazol-2(3H)-ylidene) 
thiazolidin-4-ones  6,  respectively,  using  as  starting  material  the  4-thiazoline-2-thiones  1  and                               
3-methyl-2-thioxo-1,3-thiazolidin-4-one  3.    The  transformation  of  the  tosylate  salts  5  into  their  arylimino 
derivatives 6 has not been reported to date.  
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Introduction 
 
  It is well known that thiazole and fused heterocyclic thiazoles derivatives are found to be 
associated  with  various  biological  activities  such  as  antibacterial,  antifungal  and  anti-
inflammatory activities
1-4.  The 4-thiazolidinone derivatives have played an important role in 
medicinal chemistry.  Moreover, the importance of the research carried out is due to their 
broad  spectrum  of  biological  activity,  such  as  anti-HIV
5,6,  antimycobacterial
7, 
antiproliferative
8, antimicrobial
9,10, anti-inflammatory
11,12, anticancer
13, and antifungal
14. 
  2-Heteroarylimino-1,3-thiazolidin-4-ones  in  particular  thiazolimino-  and  benzothiazol 
imino-types, have been described in the literature and used as scaffolds for preparing a range 
antibacterial and antifungal compounds
15-17, however, derivatives bearing a bis(thiazol-2(3H)-
ylidene moiety as ring have not yet been known. 
  On the other hand, it has been reported in the literature that rhodacyanine dyes, designed 
by  using  the  DLC  (π-delocalized  lipophilic  cation)  hypothesis
18,  exhibit  potent  in  vitro 
antimalarial activity  against Plasmodium falciparum and antitumor activity
19,20. Mediterr.J.Chem., 2014, 2(6),  S. Kasmi-Mir et al.  720 
 
 
  Furthermore, the azarhodacyanines may be considered analogous to the rhodacyanine dyes 
and  have  been  previously  synthesized  and  designed  as  second  generation  of  antimalarial 
rhodacyanines.    Thus,  these  azarhodacyanines  were  obtained  by  condensation  of  3-ethyl-                
5-(1-methylquinolin-2-ylidene)-2-(3-methylthio)-4-oxathiazolinium  p-toluenesulfonate  with 
2-minomethylpyridinium salt in the presence of triethylamine, in refluxing acetonitrile for  
12h in 71% yield
21 (Scheme 1). 
 
Scheme 1.  1-Methyl-2-{[3-ethyl-5-(1-methylquinolin-2(1H)-ylidene)-4-oxothiazolidin-                                 
2-(pyridin-2-ylimino]methyl}pyridinium chloride (azarhodacyanine) 
 
  In view of the biological importance and in continuation of our previous work in which we 
have studied the beneficial effect of microwave irradiation on the condensation reaction for 
the synthesis  rhodacyanines analogues
22, we report herein an efficient  microwave-assisted 
protocol  for  the  synthesis  of  new  aryliminothiazolylidene-2-thiazolidin-4-ones  (6)  from                  
2'-(methylthio)-4'-oxo-3H,4'H-[2,5-bithiazolylidene]-3'-ium tosylates (5).  This method was 
developed previously in our laboratory
22 and used the condensation of the starting material 
with aromatic amines in the presence of triethylamine. 
  In  this  paper,  4-thiazoline-2-thione  (1)
23  as  starting  material  was  transformed  into 
aryliminothiazolylidene-2-thiazolidin-4-ones  (6)  which  have  not  been  reported  to  date.  
Hence, it is through of interest to accommodate 2-heteroarylimino-1,3-thiazolidin-4-ones and 
thiazole moieties in a single molecular framework and screen for their biologically activities. 
  The  azarhodacyanines  (7a,f)  were  obtained  by  simple  quaternization  from  the 
corresponding aryliminothiazolylidene-2-thiazolidin-4-ones (6j,l). 
 
Results and Discussion 
 
  Initially, a synthesis of 4-thiazoline-2-thione 1
23-26 by Hantzsch’s cyclization is used for 
preparing  the  aryliminothiazolylidene-2-thiazolidin-4-ones  6  under  microwave  conditions 
(scheme 1).  Two types of heating, conventional and the microwave activation were used.   
  The  reaction  under  microwave  was  run  at  a  frequency  of  2.45  GHz  with  continuous 
irradiation power from 0 to 300W.  The reaction temperature in the microwave cavity was 
measured with an IR captor (infrared thermometry) and the software algorithm regulates the 
microwave out-put power so that the preselected maximum temperature is maintained for the 
desired reaction/irradiation time.  Synthesis of 6 was accomplished by a four-step sequence 
from 4-thiazoline-2-thiones 1.  S-methylation of 1 gave access to thiazolium salt 2 which was 
transformed into 5-(thiazol-2(3H)-ylidene)-2-thioxothiazolidin-4-ones 4 by condensation with 
N-methylrhodanine  3in  the  presence  of  triethylamine.    Activation  by  S-methylation  of  4 
furnished salt 5
22 (Scheme 2). Mediterr.J.Chem., 2014, 2(6),  S. Kasmi-Mir et al.  721 
 
 
 
Scheme 2.  Synthetic approach to obtain aryliminothiazolylidene-2-thiazolidin-ones (6a,j) 
Reagents and conditions:(i) MeI (2 equiv), acetone, rt, 24 h. (ii) Et3N (1.5 equiv), N-methylrhodanine 
(1 equiv), acetone, rt, 24 h. (iii) Methyl p-toluenesulfonate (MPTS) (3 equiv), DMF, 120°C, 4 h. (iv) 5 
(1.2 equiv), ArNH2 (1 equiv), Et3N (1.5 equiv), MeCN, reflux, 4-8 h; MW: 5 (1.2 equiv), ArNH2 (1 
equiv), Et3N (1.5 equiv), MeCN, 90°C, 8 to 12 min. 
   
  The  target  aryliminothiazolylidene-2-thiazolidin-4-ones  (6a,l)  were  prepared  from  a 
mixture of salt 5 and aromatic amines in presence of triethylamine (in 64-82% yield) by 
heating  (at  90°C)  and  stirring  (about  4-8  h)  in  acetonitrile.    In  microwave-assisted                  
synthesis conditions, the yields of the new compounds were better than conventional method 
(78-95% yield) and the reaction time in 8-12 minutes (Table 1). 
 
Table1.  Results for (6a,l) syntheses under conventional method and under MW irradiation 
 
Classical heating 
Method A 
MW
 b 
Method B 
Entry  6  R1  Ar 
Time 
(min) 
Yield
a 
(%)
 
Time 
(min) 
Yield
a 
(%)
 
1  6a  Me  Ph  360  82  10  92 
2  6b  Ph  Ph  360  64  8  78 
3  6c  pMeC6H4  Ph  300  79  10  90 
4  6d  Me  pMeC6H4  240  71  10  94 
5  6e  Ph  pMeC6H4  240  73  8  92 
6  6f  pMeC6H4  pMeC6H4  360  80  10  91 
7  6g  Me  2-Pyridyl  300  75  8  90 
8  6h  Ph  2-Pyridyl  300  72  10  93 
9  6i  pMeC6H4  2-Pyridyl  300  73  10  95 
10  6j  Me  4-Me-2-Pyridyl  480  78  10  88 
11  6k  Ph  4-Me-2-Pyridyl  480  80  12  90 
12  6l  pMeC6H4  4-Me-2-Pyridyl  480  78  10  86 
a Isolated yields 
b P = 90W, T= 90°C 
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  Alkylation of aryliminothiazolylidene-2-thiazolidin-4-ones (6j,l) via quaternization of the 
pyridine  nitrogen  atom  with  methyl  iodide  or  methyl  p-toluenesulfonate,  gave  the 
corresponding azarhodacyanines (7a,f) in 43-70% yield under classical heating, during 6-8 h, 
at  90°C in refluxing  acetonitrile, and  in 64-85%  yield, during 8-15 min, at  120°C under 
microwave irradiation. The reaction is depicted in scheme 1 and the results are summarized in 
Table 2. 
  
Scheme 3.  Synthesis of azarhodacyanines (7a,f) 
Reagents and conditions: 6 (1 equiv), MPTS (7 equiv) or MeI (10 equiv), MeCN, reflux; 6-8 h or 
MW, 10-15 min at 120°C for MPTS and at 60°C for MeI. 
 
Table 2.  Results for Azarhodacyanines (7a,f) 
  Classical heating 
Method C 
MW 
Method D 
Entry  7  R1  X  Time 
(min) 
Yield
a(%)  Time (min)  Yield
a(%)
 
1  7a  Me  pTos  420  55  10  75 
2  7b  Me  I  360  43  8  64 
3  7c  Ph  pTos  420  44  10  77 
4  7e  Ph  I  480  45  13  70 
5  7f  pMeC6H4  pTos  420  70  15  85 
6  7f  pMeC6H4  I  420  57  8  69 
a Isolated yield 
 
  The  results  summarized  in  table  1  and  2  show  that  in  microwave-assisted  synthesis 
conditions, the yields of the new compounds 6 and 7 were better than conventional method. 
The  difference  in  reaction  time  between  these  two  condensation  conditions  methods 
procedure was evident. 
  The structural elucidation of compounds (6 and 7) is based on spectroscopic data (
1H and 
13C NMR) and mass spectrometry HRMS.  The attribution for (2Z, 5E)-stereochemistry of 
compounds (6 and 7) was based on the literature data
19,27. 
  The 
1H NMR of compounds (6 and 7) exhibit a typical signal for the H-5 proton of the 
thiazolic ring around 5.98-6.63 ppm for (6) and 6.45-6.85 ppm for (7), while the 
1H NMR 
spectra of 6 showed N-CH3 as a singlet at 3.53-4.10 ppm.  The 
13C NMR spectra of (6 and 7) 
were characterized by the presence of C-2 rhodanine C=N at 153.5-159.7 ppm for (6) and 
157.6-160.1 ppm for (7); and C=O the C-4 rhodanine at 163.2-166.6 ppm for (6) and 162.8-
163.2 ppm for (7). 
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Conclusion 
 
  The  microwave-assisted  condensation  reaction  of  2'-(methylthio)-4'-oxo-3H,4'H-                   
[2,5-bithiazolylidene]-3'-ium  tosylates  (5a,c)  with  aromatic  amines,  is  a  technique  which 
gives  satisfactory  experimental  results,  affording  good    to  high  yields  of  new 
aryliminothiazolylidene-2-thiazolidin-4-ones  (6a,l)  and  their  azarhodacyanines  derivatives 
(7a,f), in significantly shorter reaction times compared to classical conditions.  Up to now, 
this new approach has never been reported and may be a complement to those existing in the 
literature. This class of compound will be soon tested for biological activities. 
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Experimental Section 
 
  Melting points were determined on a Kofler apparatus.
1H NMR spectra were recorded on 
Bruker  ARX  200  (200  MHz),  Bruker  250  MHz  and  Bruker  AC  300P  (300  MHz) 
spectrometers and 
13C NMR spectra on Bruker AC 300P (75 MHz) spectrometer in CDCl3 or 
DMSO-d6.  Chemical  shifts  are  expressed  in  parts  per  million  downfield  from 
tetramethylsilane as an internal standard.  The mass spectra (MS) on a VARIANT MAT 311 
at a ionizing potential of 70 eV in the Centre de Measures Physiques de l’Ouest (CRMPO, 
Rennes).  Reactions  under  microwave  were  performed  in  a  PROLABO  Synthewave
(R)                   
402 (2.45 GHz) microwave reactor with a single focused system. All solvents and reagents 
were  purchased  from  Acros  Organics  and  Aldrich  Chemic  and  used  without  further 
purification unless otherwise stated.  
 
  Preparation of the compounds 1, 2, 3,4 and 5 
    Compounds (1a,c) 
  The preparation of the compounds 1 was obtained according to the literature
22,26 from 
disulfide carbon, amine in aqueous ammonia, and chloroacetone by Hantzsch’s cyclization. 
 
3,4-Dimethyl-1,3-thiazole-2(3H)-thione (1a).  Beige crystals; yield = 85%; mp116°C. 
4-Methyl-3-phenyl-1,3-thiazole-2(3H)-thione (1b).  White crystals; yield = 82%;                        
mp =151°C. 
4-Methyl-3-(4-methylphenyl)-1,3-thiazole-2-(3H)-thione (1c).  Beige crystals; yield= 97%; 
mp = 112°C. 
    Compounds (2a,c) 
  The alkylation of 1 (30 mmol, 1equiv) with iodomethane (60 mmol, 2equiv) gave (2a-c).
22 
 
3,4-Dimethyl-2-(methylthio)-1,3-thiazol-3-ium iodide (2a): pale yellow needles; yield: 74%; 
mp = 163°C. 
4-Methyl-3phenyl-2-(methylthio)-1,3-thiazol-3-ium iodide (2b): pink needles; yield: 70%; 
mp = 194°C. 
4-Methyl-3-(4-methylphenyl)-2-(methylthio)-1,3-thiazol-3-ium iodide (2c):orangecrystals; 
yield: 80%; mp = 162°C. Mediterr.J.Chem., 2014, 2(6),  S. Kasmi-Mir et al.  724 
 
 
    Compound 3 
  The  preparation  of  the  compounds  3  was  obtained  according  to  the  literature,
22  from 
disulfide  carbon,  amine  in  aqueous  ammonia  and  chloroacetic  acid  and  was  purified  by 
recrystallisation from aqueous ethanol. 
 
3-Methyl-2-thioxo-1,3-thiazolidin-4-one (3):Yellow crystals; yield = 75%; mp = 69- 71°C 
(lit. 71°C
28). 
    Compounds (4a,c)
22 
In a 250 mL round-bottomed flask, 10 mmol of salt 2, 10 mmol of N-methylrhodanine 3, 20 
mL of acetone, and 2 mL of triethylamine are placed.  After stirring at room temperature 
during 4 h, a yellow-green solid is formed. It is filtered off and washed several time with 
acetone. 
 
(5E)-3-Methyl-5-(3,4-dimethylthiazol-2(3H)-ylidene)-2-thioxothiazolidin-4-one  
(4a): yellow-green powder; yield = 95%; mp > 260°C. 
(5E)-3-Methyl-5-(4-methyl-3-phenylthiazol-2(3H)-ylidene)-2-thioxothiazolidin-4-one 
(4b): yellow powder; yield = 82% mp > 260°C. 
(5E)-3-Methyl-5-(4-methyl-3-p-tolylthiazol-2(3H)-ylidene)-2-thioxothiazolidin-4-one 
(4c): brown yellow powder; yield = 94%; mp >260°C 
 
General Procedure for Salts Tosylates (5a,c)
22 
 
  A mixture of 4 (5 mmol), 15 mmol of MPTS (methyl p-toluenesulfonate), and 3 mL of 
DMF is stirred at 110–120°C during 4 h.  The reaction mixture is cooled and 50 mL of 
acetone is added.  After completion, the mixture is cooled down to refrigerated for one night. 
The resulting salt 5 is filtered off and dried under vacuum. 
 
(5E)-3-Methyl-5-(3,4-dimethyl-1,3-thiazol-2-ylidene)-2-(methylthio)-4-oxo-1,3thiazolium 
p-toluenesulfonate (5a): 
Yellow-green powder; yield = 70%; mp= 253°C. 
1H NMR (300 MHz, CDCl3):                            
7.90 (d, 2H, J = 8.0 Hz); 7.18 (d, 2H, J = 8.0 Hz); 7.02 (s, 1H, H-5); 4.12 (s, 3H, CH3N-
thiazol); 3.73 (s, 3H, CH3N
+); 2.99 (s, 3H, CH3-S); 2.50 (s, 3H, CH3-tosyl);                             
2.11 (s, 3H, CH3-thiazol). 
(5E)-3-Methyl-5-(4-methyl-3-phenyl-1,3-thiazol-2-ylidene)-2-(methylthio)-4-oxo-1,3 
thiazolium p-toluenesulfonate (5b): 
Deep green crystals; yield = 80%; mp = 206°C. 
1H NMR (300 MHz, CDCl3):                       
7.79–7.74 (m, 5H, Ar); 7.72 (d, 2H, J = 8.0 Hz); 7.69 (d, 2H, J = 8.0 Hz); 7.12 (s, 1H, H-5); 
3.50 (s, 3H, CH3N
+); 2.60 (s, 3H, CH3-S); 2.29 (s, 3H, CH3-tosyl); 2.08 (s, 3H, CH3-thiazol). 
(5E)-3-Methyl-5[4-methyl-3-(4-methylphenyl)-1,3-thiazol-2-ylidene]-2-(methylthio)-                 
4-oxo-1,3-thiazolium p-toluenesulfonate (5c): 
Deep green crystals; yield =68%; mp = 198°C. 
1H NMR (300 MHz, CDCl3) δ:                         
7.76 (d, 2H, J = 8.0 Hz); 7.57 (d, 2H, J = 8.1 Hz); 7.32 (d, 2H, J = 8.2 Hz);                                 
7.11 (d, 2H, J = 8.0 Hz); 7.05 (s, 1H, H5); 3.56 (s, 3H, CH3N
+); 2.73 (s, 3H, CH3S);                     
2.48 (s, 3H, p-CH3-thiazol); 2.32 (s, 3H,CH3-tosyl); 2.11 (s, 3H,CH3-thiazol). 
 
The spectral data of the compounds 1, 2, 3, 4 and 5 were identical with reported ones
22. 
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II-General procedure for the preparation of aryliminothiazolylidene-2-thiazolidin-                      
    2-ones (6a,l) 
(a)Classical heating:  Method A 
To a solution of the appropriate amines (2.5 mmol) in 20mL of anhydrous acetonitrile, the 
salts tosylates 5 (3mmol) and triethylamine (0.4ml, 3mmol, 0.30g) were added and reaction 
mixture was refluxed for 4-8h.  Evaporation of the solvent was followed by purification of the 
residue by recrystallization from ethanol. 
 
(b)Microwave-irradiation (MW):  Method B 
In an open cylinder quartz reactor (ф = 1.5cm) are placed (1.8 mmol) the appropriate salt 
5, aromatic amine (1.5 mmol), acetonitrile (2mL) and triethylamine (0.20 mL, 0.152g, 1.5 
mmol).    The  stirred  mixture  was  irradiated  at  90°C  (90W,  Synthewave
(R)  402)  with  an 
appropriate reaction time from 8 to 12min.  The crude reaction mixture was cooled at room 
temperature; the residue was recrystallized from ethanol. 
 
(2Z,5E)-3-Methyl-5-(3,4-dimethylthiazol-2(3H)-ylidene)-2-(phenylimino)thiazolidin-                
4-one(6a): 
Green dark crystal; mp = 203°C. 
1H NMR (CDCl3) δ: 7.20 (m, 5H, Ar); 6.02 (s, 1H,H-5); 
3.50 (s,3H, CH3N rod); 3.41 (s, 3H, CH3N thiazol); 2.11 (s, 3H, CH3-thiazol). 
13C NMR 
(CDCl3)δ: 165.3 (C=O); 155.4 (C=N); 152.8 (C-2 thiazol); 149.6; 136.1 (C-4 thiazol); 129.2, 
123.7, 121.8; 102.5 (dq, J = 190.1 and 5.4 Hz, C-5 thiazol); 78.8 (C-5 rod); 34.2 (q, J = 140.2 
Hz, CH3-N thiazol); 29.0 (q, J = 140.1 Hz, CH3-N rod); 14.5 (qd, J = 129.5 and 2.5 Hz, CH3-
thiazol). HRMS (m/z): found 157.0020 (calc. for C15H15N3OS2, M
+ requires: 157.0099). 
 (2Z,5E)-3-Methyl-5- (4-methyl-3-phenylthiazol-2 (3H)-ylidene)-2-(phenylimino) 
thiazolidin-4-one (6b): 
Braun dark crystal; mp = 240°C. 
1H NMR (CDCl3) δ: 7.40-6.70 (m, 10H); 6.04 (s, 1H, H-5); 
3.20 (s, 3H,  CH3-N rod); 1.71 (s, 3H,  CH3  thiazol). 
13C NMR  (CDCl3)  δ:  165.6 (C=O);                
153.5 (C=N); 152.8 (C-2 thiazol); 148.9; 136.0 (C-4 thiazol); 131.1; 130.4; 129.9; 129.8; 
129.5; 129.2; 128.7; 123.4; 121.7; 101.7 (dq, J = 190.1 and 5.2Hz, C-5 thiazol); 80.0 (C-5 
rod); 28.7 (q, J = 140.8 Hz, CH3-N rod); 14.5 (qd, J = 129.8 and 2.4 Hz, CH3-thiazol). HRMS 
(m/z): found 379.0826 (calc. for C20H17N3OS2, M
+ requires: 379.0813). 
 (2Z,5E)-3-Methyl-5-[4-methyl-3-[4-methylphenyl)]thiazol-2(3H)-ylidene)-
2(phenylimino) thiazolidin-4-one (6c): 
Braun crystal; mp >260°C. 
1H NMR (CDCl3) δ: 7.30 (m, 5H); 6.80 (d, 2H, J = 7.1 Hz); 6.3 
(d, 2H, J = 7.0 Hz); 6.10 (s, 1H, H-5); 3.31 (s,3H, CH3N rod); 2.30 (s, 3H, CH3-p-tolyl); 1.82 
(s, 3H, CH3-thiazol). 
13C (CDCl3) δ: 165.9 (C=O); 154.3 (C=N); 152.0 (C=N pyridine); 151.6 
(C2 thiazol); 141.0; 136.1 (C4 thiazol); 132.7;130.1; 129.8; 128.7; 123.5; 121.9; 101.6 (dq, J = 
190.1  and  5.2  Hz,  C-5  thiazol);  80.0  (C-5  rod);  28.7  (q,  J  =  140.1  Hz,  CH3-N  rod);                 
21.1 (q, J = 126.8 and 4.4 Hz, CH3-p-tolyl); 14.5 (qd, J = 129.0 and 2.5 Hz, CH3-thiazol). 
HRMS (m/z): found 393.0966 (calc. for C21H19N3OS2, M
+ requires: 393.0970). 
(2Z,5E)-2-[4-(Methylphenyl)imino]-3-methyl-5-(3,4-dimethylthiazol-2(3H)-ylidene) 
thiazolidin-4-one (6d): 
Yellow crystal; mp = 203°C. 
1H NMR (CDCl3) δ: 7.11 (d, 2H, J = 7.6 Hz);6.90 (d, 2H, J = 
7.7 Hz); 5.58 (s, 1H, H-5); 3.48 (s, 3H, CH3N rod); 3.34 (s, 3H, CH3N thiazol); 2.30 (s, 3H, 
CH3-p-tolyl); 2.08 (s,3H,  CH3-thiazol). 
13C NMR (CDCl3)  δ: 165.4 (C=O);  155.3 (C=N); 
152.7 (C-2 thiazol); 147.0; 136.1 (C-4 thiazol); 133.1; 129.9, 121.5, 102.4 (qd, J = 190.1 and 
5.3 Hz, C-5 thiazol); 77.6 (C-5 rod); 34.1 (q, J = 140.1 Hz, CH3-N thiazol); 29.0 (q, J = 140.0 Mediterr.J.Chem., 2014, 2(6),  S. Kasmi-Mir et al.  726 
 
 
Hz, CH3-N rod); 20.9 (qt, J = 126.9 and 4.3 Hz, CH3-p-tolyl); 14.5 (qd, J = 129.3 and 2.5 Hz, 
CH3-thiazol). HRMS (m/z): found 331.0802 (calc. for C16H17N3OS2, M
+ requires: 331.0813). 
(2Z,5E)-2-[(4-Methylphenyl)imino]-3-methyl-5-(4-methyl-3-phenylthiazol-2(3H)-ylidene) 
thiazolidin-4-one (6e). 
Green crystal; mp >260°C. 
1H NMR (CDCl3) δ: 7.4 (m, 5H); 7.1 (d, 2H, J = 8.2 Hz); 7.0 (d, 
2H, J = 8.8 Hz); 6.8 (s, 1H, H-5); 3.50 (s, 3H, CH3-N rod); 2.30 (s, 3H, CH3-p-tolyl); 1.90 (s, 
3H,  CH3-thiazol). 
13C  NMR  (CDCl3)  δ:  163.2  (C=O);  157.9  (C=N);  152.0  (C-2  thiazol); 
137.5; 137.5; 136.1 (C-4 thiazol); 134.6; 131.5; 130.5; 129.4; 123.7; 104.6 (dq, J = 190.2 and 
5.4 Hz, C-2 thiazol); 78.0 (C-5 rod); 30.0 (q, J = 141 Hz, CH3-N rod); 21.1 (qt, J = 126.4 and 
4.4  Hz,  CH3-p-tolyl);  14.29  (qd,  J  =  129  and  2.4Hz,  CH3-thiazol).  HRMS  (m/z):  found 
393.0966 (calc. for C21H19N3OS2, M
+ requires: 393.0970). 
(2Z,5E)-2-[(4-Methylphenyl)imino]-3-methyl-5-[4-methyl-3-(4-methylphenyl)thiazo-
2(3H)-ylidene]thiazolidin-4-one (6f): 
Green powder; mp >260°C. 
1H NMR (CDCl3/CF3COOH) δ: 7.30 (d, 2H, J = 9 Hz); 7.20 (d, 
2H, J = 9.0 Hz); 7.00 (d, 2H, J = 8.2 Hz); 7.00 (d, 2H, J = 8.2 Hz); 6.60 (s, 1H, H-5); 3.60 (s, 
3H, CH3-N rod); 2.30 (s, 3H, CH3-p-tolyl); 2.10 (s, 3H, CH3-p-tolylimino); 2.01 (s, 3H, Me-
thiazol). 
13C NMR (CDCl3/CF3COOH) δ: 166.6 (C=O); 159.7 (C=N);  152.9(C-2 thiazol); 
143.2; 139.7; 138.7 (C-4 thiazol); 132.5; 131.3; 130.5; 129.0; 124.8; 117.2; 113.3; 106.0 (dq, 
J = 190.1 and 5.2 Hz, C-5 thiazol); 78.3 (C-5 rod); 29.9 (q, J = 140.1 Hz, CH3-N rod); 21.0 (q, 
J = 127.1 and 4.2 Hz, CH3-p-tolyl); 20.9 (qt, J = 126.8 and 4.4 Hz, CH3-p-tolyl); 14.1 (qd, J = 
129.2 and 2.5 Hz, CH3-thiazol). HRMS (m/z): found 407.1114 (calc. for C22H21N3OS2, M
+ 
requires: 407.2610). 
(2Z,5E)-3-Methyl-5-(3,4-dimethylthiazol-2(3H)-ylidene)-2-(pyridin-2-ylimino)thiazolidin 
-4-one(6g): 
Green dark powder; mp = 219°C. 
1H NMR (CDCl3) δ:8.40 (d, 1H, J = 5.1 Hz);7.60 (t, 1H, J = 
4.5 Hz); 7.20 (d, 1H, J = 5.0 Hz); 6.90 (t, 1H, J = 5.1 Hz); 6.10 (s, 1H, H-5); 3.80 (s, 3H, 
CH3-N rod); 3.50 (s, 3H, CH3-N thiazol); 2.20 (s, 3H, CH3-thiazol). 
13C NMR (CDCl3) δ: 
165.0 (C=O); 159.1 (C=N); 157.4 (C=N pyridine); 155.0 (C-2 thiazol); 146.3; 137.7 (C-4 
thiazol); 120.8; 117.9; 103.6 (C-5 thiazol); 82.6 (C-5 rod); 35.4 (CH3-N thiazol); 30.1 (CH3-N 
rod); 15.0 (CH3-thiazol). HRMS(m/z): found 318.0596 (calc. for C14H14N4OS2, M
+ requires: 
318.0609). 
(2Z,5E)-3-Methyl-5-(4-methyl-3-phenylthiazol-2(3H)-ylidene)-2-(pyridin-2-ylimino) 
thiazolidin -4-one (6h): 
Green dark crystals; mp = 209°C. 
1H NMR (CDCl3) δ: 8.20 (d, 1H, J = 6.0Hz);7.40 (m, 5H); 
7.10 (t, 1H, J = 4.5 Hz); 7.10 (d, 1H, J = 5.1 Hz); 6.80 (t, 1H, J = 5 Hz); 6.20 (s, 1H, H-5); 
3.40 (s, 3H, CH3-N rod); 1.90 (s, 3H, CH3-thiazol). 
13C NMR (CDCl3) δ: 165.7 (C=O); 158.9 
(C=N); 156.5 (C=N pyridine); 155.2 (C-2 thiazol); 145.5; 137.8; 136.7; 130.8; 130.6; 130.4; 
129.6;  120.4;  117.7;  102.8  (C-5  thiazol);  84.7  (C-5  rod);  29.7  (CH3-N  rod);  15.0  (CH3-
thiazol). HRMS (m/z): found 380.0799 (calc. for C19H16N4OS2, M
+ requires: 380.0766). 
(2Z,5E)-3-Methyl-5-[4-methyl-3-(4-methylphenyl)thiazol-2(3H)-ylidene]-2-(pyridin-2-
ylimino)thiazolidin-4-one (6i): 
Braun powder; mp = 236°C. 
1H NMR (CDCl3) δ:8.10 (d, 1H, J = 6.0 Hz);7.50 (t, 1H, J = 4.5 
Hz); 7.40 (d, 2H, J = 8.1 Hz); 7.20 (d, 2H, J = 8.1 Hz); 7.01 (d, 1H, J = 5.0 Hz); 6.8 (t, 1H, J 
= 5.0 Hz); 6.10 (s, 1H, H-5); 3.40 (s, 3H, CH3-N rod); 2.60 (s, 3H, CH3-p-tolyl); 1.90 (s, 3H, 
CH3-thiazol). 
13C NMR (CDCl3) δ: 165.7 (C=O); 159.1 (C=N); 156.6 (C=N pyridine); 152.2 
(C-2 thiazol); 145.6; 141.34 (C-4 thiazol); 138.2; 137.5; 130.3; 129.9; 117.7; 116.8; 104.3 (C-Mediterr.J.Chem., 2014, 2(6),  S. Kasmi-Mir et al.  727 
 
 
5 thiazol); 88.0 (C-5 rod); 29.7 (CH3-N rod); 21.9 (CH3-p-tolyl); 15.0 (CH3-thiazol). HRMS 
(m/z): found 394.0912 (calc. for C20H18N4OS2, M
+ requires: 394.0922). 
(2Z,5E)-2-(4-Methylpyridin-2-ylimino)-3-methyl-5-(3,4-dimethylthiazol-2(3H)-ylidene) 
thiazolidin-4-one (6j): 
Green crystals; mp = 215°C .
1H NMR (CDCl3) δ: 8.20 (d, 1H, J = 5.1 Hz); 6.90 (s, 1H); 6.60 
(d, 1H, J = 5.0 Hz); 6.00 (s, 1H, H-5); 3.70 (s, 3H, CH3-N rod); 3.40 (s, 3H, CH3-thiazol); 
2.30 (s, 3H, CH3-pyridine); 2.03 (s, 3H, CH3-thiazol). 
13C NMR (CDCl3) δ: 164.6 (C=O); 
158.8  (C=N);  156.8  (C=N  pyridine);  154.5  (C-2  thiazol);  148.4  (C-Me  pyridine);  145.6; 
136.4; 120.9; 103.1 (dq, J = 190.3 and 5.4 Hz, C-5 thiazol); 82.1 (C-5 rod); 35.0 (q, J = 140.8 
Hz, CH3-N thiazol); 29.5 (q, J = 141.1 Hz, CH3-rod); 20.9 (qt, J = 126.0 and 4.3 Hz, CH3-
pyridine); 14.8 (qd, J = 129.5 and 2.5 Hz, CH3-thiazol). HRMS (m/z): found 332.6771 (calc. 
for C15H16N4OS2, M
+ requires 332.0766). 
(2Z,5E)-2-(4-Methylpyridin-2-ylimino)-3-methyl-5-(4-methyl-3-phenylthiazol-2(3H)-
ylidene)thiazolidin-4-one (6k): 
Yellow-green crystal; mp 235°C. 
1H NMR (CDCl3) δ:7.90 (d, 1H, J = 5.1 Hz); 7.40 (m, 5H); 
6.90 (s, 1H); 6.60 (d, 1H, J = 5.0 Hz); 6.20 (s, 1H, H-5); 3.40 (s, 3H, CH3-N rod); 2.3 (s, 3H, 
CH3-pyridine); 1.90 (s, 3H, CH3-thiazol). 
13C NMR (CDCl3) δ: 165.4 (C=O); 158.7 (C=N); 
155.9 (C=N pyridine); 154.5 (C-2 thiazol); 148.2; 144.8; 136.3 (C-4 thiazol); 130.3; 130.2; 
129.9; 120.4; 118.7; 102.3 (dq, J = 190.0 and 5.0 Hz, C-5 thiazol); 84.4 (C-5 rod); 29.2 (q, J = 
140.0 Hz, CH3-N rod); 20.9 (qt, J = 127.7 and 5.1 Hz, CH3-pyridine); 14.6 (qd, J = 129.7 and 
3 Hz). HRMS (m/z): found 394.0930 (calc. for C20H18N4OS2, M
+ requires: 394.0992). 
(2Z,5E)-2-(4-Methylpyridin-2-ylimino)-3-methyl-5-[4-methyl-3-(4-methylphenyl)thiazol-
2(3H)-ylidene]thiazolidin-4-one (6l): 
Braun crystal; mp = 238°C. 
1H NMR (CDCl3) δ: 7.80 (d, 1H, J = 5.1 Hz); 7.30 (d, 2H, J = 8.1 
Hz); 7.20 (d, 2H, J = 8.2 Hz); 6.80 (s, 1H); 6.10 (s, 1H, H-5); 3.30 (s, 3H, CH3-N rod); 2.49 
(s, 3H, CH3-pyridine); 2.20 (s, 3H, CH3-p-tolyl); 1.20 (s, 3H, CH3-thiazol). 
13C NMR (CDCl3) 
δ:  165.3  (C=O);  158.8  (C=N);  156.1  (C=N  pyridine);  148.2;  144.9;  140.9;  136.4;  133.6; 
130.0; 129.9; 120.5; 118.8; 102.1 (dq, J = 190.1 and 5.3 Hz, C-5 thiazol); 84.2 (C-5 rod); 29.2 
(q, J = 140.9 Hz, CH3-N rod); 21.4 (qt, J = 126.9 and 4.3 Hz, CH3-p-tolyl); 20.9 (qt, J = 127.0 
and 4.4 Hz, CH3-pyridine); 14.5 (qd, J = 129.8 and 2.3 Hz, CH3-thiazol). HRMS (m/z): found 
408.1065 (calc. for C21H20N4OS2, M
+ requires 408.1079). 
 
IV-General  Procedure  for  the  preparation  of  azarhodacyanines  (7a,f)  by 
quarternization of (6j,l) 
(a) Classical heating: Method C 
In a 250 mL round bottom flask are placed 1mmol of (6j,l), 7 mmol of MPTS (methyl p-
toluenesulfonate)  or  10  mmol  of  MeI,  20  mL  of  acetonitrile.    The  reaction  mixture  was 
refluxed during 6-8 h. After cooling to room temperature and solvent evaporation, the residue 
was washed with acetone. 
 
(b) Microwave-irradiation: Method D 
In an open quartz reactor are added 1mmol of imine (6j,l), 7 mmol of MPTS (methyl p-
toluenesulfonate) or 10 mmol of MeI.  The mixture was exposed to microwave at 120°C (90 
W, Synthewave
(R), 402), for MPTS or 60°C (90 W, Synthewave
(R), 402) for MeI during 10-15 
min.  The residue was washed with acetone. 
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4-Methyl-2-[3-methyl-5-(3,4-dimethylthiazol-2(3H)-2-ylidene)-4-oxothiazolidin-2-ylidene 
amino]-1-methylpyridinium p-toluenesulfonate (7a): 
Red crystals; mp = 122°C. 
1H NMR (CDCl3) δ:8.40 (d, 1H, J = 5.9 Hz); 7.62 (d, 2H, J = 8.0 
Hz); 7.30 (d, 2H, J = 7.9 Hz); 7.03 (d, 1H, J = 5.7 Hz); 6.91 (s, 1H,); 6.5 (s, 1H, H-5); 3.89 (s, 
3H,  CH3-N
+);  3.56  (s,  3H,  CH3-N  thiazol);  3.20  (s,  3H,  CH3-N  rod);  2.45  (s,  3H,  CH3-
pyridine); 2.37 (s, 3H, CH3-tosyl); 2.32 (s, 3H, CH3-thiazol). 
13C NMR (CDCl3) δ: 162.8 
(C=O); 160.1 (C=N); 158.8 (C=N pyridine); 152.2 (C-2 thiazol); 145.1; 143.5; 142.6; 139.5 
(C-4 thiazol); 131.2; 129.6; 120.5; 117.7; 110.6; 104.9 (C-5 thiazol); 88.7 (C-5 rod); 42.5 
(CH3-N
+); 35.7 (CH3-N rod); 30.3 (CH3-N thiazol); 22.0 (CH3-p-tolyl); 21.1 (CH3-tosyl); 14.7 
(CH3-thiazol). HRMS (m/z): found 347.1000 (calc. for C16H19N4OS2, M
+ requires: 347.1003). 
4-Methyl-2-[3-methyl-5-(3,4-dimethylthiazol-2(3H)-2-ylidene)-4-oxo-thiazolidin-2-
ylideneamino]-1-methylpyridinium iodide (7b): 
Green powder; mp >260°C. 
1H NMR (DMSO ) δ: 8.60 (d, 1H, J = 6.6Hz); 7.60 (s, 1H); 7.3 
(d, 1H, J = 6.5 Hz); 6.80 (s, 1H, H-5); 4.00 (s, 3H, CH3-N
+); 3.80 (s, 3H, CH3-N rod); 3.40 (s, 
3H,CH3-N thiazol); 2.50 (s, 3H, CH3-pyridine); 2.30 (s, 3H, CH3-thiazol). 
13C NMR (CDCl3) 
δ: 163.2 (C=O); 161.1 (C=N
+); 159.9 (C=N); 152.3 (C-2thiazol); 140.2; 139.6 (C-4 thiazol); 
120.6; 117.2; 110.1; 105.1 (C-5 thiazol); 79.7 (C-5 rod); 42.9 (CH3-N
+); 36.2 (CH3-N rod); 
30.6 (CH3-N thiazol); 22.4 (CH3-pyridine); 14.8 (CH3-thiazol). HRMS (m/z): found 347.1000 
(calc. for: C16H19N4OS2, M
+requires: 347.1003). 
4-Methyl-2-[3-methyl-5-(3-phenyl-4-methylthiazol-2(3H)-2-ylidene)-4-oxo-thiazolidin-          
2-ylideneamino]-1-methylpyridiniump-toluenesulfonate (7c): 
Orange crystal; mp = 207°C.
1H NMR (CDCl3)δ: 9.04 (d, 1H, J = 6.0Hz); 7.83 (d, 2H, J = 7.9 
Hz); 7.70 (m, 5H); 7.20 (d, 1H, J = 5.3 Hz); 7.10 (d, 2H, J = 7.8 Hz); 6.90 (s, 1H); 6.50 (s, 
1H, H-5); 4.00 (s, 3H, CH3-N
+); 3.50 (s, 3H, CH3-N rod); 2.40 (s, 3H, CH3-tosyl); 2.20 (s, 3H, 
Me-pyridine); 2.00 (s, 3H, CH3-thiazol). 
13C NMR (CDCl3 ) δ: 163.0 (C=O); 160.3 (C=N
+); 
157.5 (C=N); 157.3 (C-2); 153.6; 144.8; 143.6; 138.6 (C-4); 137.6; 134.9; 131.5; 130.6; 
129.8; 128.2; 120.5; 116.8; 104.8 (C-5 thiazol); 79.7 (C-5 rod); 42.9 (CH3-N
+); 29.7 (CH3N 
rod); 22.3 (CH3-pyridine); 21.3 (CH3-tosyl); 14.9 (CH3-thiazol). HRMS (m/z):                 
found 409.1153 (calc.for C21H21N4OS2, M
+requires: 409.1568). 
4-Methyl-2-[3-methyl-5-(3-phenyl-4-methylthiazol-2(3H)-ylidene)-4-oxo-thiazolidin-     
2-ylideneamino]-1-methylpyridinium iodide (7d): 
Red crystals; mp >260°C.
1H NMR (CDCl3) δ: 8.96 (d, 1H, J = 6.3 Hz); 7.60 (m, 5H); 7.20  
(d, 1H, J = 6.1Hz); 7.00 (s, 1H); 6.56 (s, 1H, H-5);4.10 (s, 3H, CH3-N
+); 3.20 (s, 3H, CH3-N 
rod); 2.50 (s, 3H, Me-pyridine); 2.00 (s, 3H, CH3-thiazol). 
13C NMR (CDCl3) δ: 162.9 (C=O); 
159.5 (C=N
+); 158.7 (C=N); 157.2 (C-2 thiazol); 146.8; 143.3; 141.3; 139.9; 129.9; 127.5; 
123.5;  118.1;  116.3;  105.1;  77.8;  44.8 (CH3-N
+); 29.8 (CH3-N rod);  22.6 (CH3-pyridine); 
14.9(CH3-thiazol).  HRMS  (m/z):  found  409.1153  (calc.for  C21H21N4OS2,  M
+requires: 
409.1157). 
4-Methyl-2-[3-methyl-5-[3-(4-methylphenyl)]-4-methylthiazol-2(3H)-2-ylidene)-4-oxo-
thiazolidin-2-ylideneamino]-1-methylpyridinium p-toluenesulfonate (7e): 
Braun crystal; mp = 134°C. 
1H NMR (CDCl3) δ: 8.70 (d, 1H, J = 6.6 Hz); 7.70 (d, 2H, J = 8.1 
Hz); 7.40 (d, 2H, J = 8.1Hz); 7.1 (d, 2H, J = 8.2Hz); 7.25 (d, 1H, J = 6.6 Hz); 7.01 (d, 2H,      
J = 8.0 Hz); 6.86 (s, 1H); 6.50 (s, 1H, H-5); 3.90 (s, 3H, CH3-N
+); 3.30 (s, 3H, CH3N-rod); 
2.40 (s, 3H, CH3-pyridine); 2.30 (s, 3H, CH3-tosyl); 2.20 (s, 3H, CH3-p-tolyl-Nthiazol);1.90 
(s, 3H, CH3-thiazol). 
13CNMR (CDCl3) δ: 162.9 (C=O); 160.2 (C=N
+); 157.6 (C=N); 157.1 
(C-2 thiazol); 153.6; 144.6; 143.9; 142.0; 138.9; 137.8; 132.1; 130.9; 129.4; 128.4; 126.0; 
120.3;  115.9;  104.7  (C-5  thiazol);  78.7  (C-5  rod);  42.3  (CH3-N
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21.9 (CH3-p-tolyl); 21.4 (CH3-pyridine); 21.1 (CH3-tosyl), 14.3 (CH3-thiazol). HRMS (m/z):                       
found 423.1315 (calc .for C22H23N4OS2, M
+requires: 423.1313). 
4-Methyl-2-[3-methyl-5-[3-(4-methylphenyl)]-4-methylthiazol-2(3H)-2-ylidene)-4-oxo-
thiazolidin-2-ylideneamino]-1-methylpyridinium iodide (7f). 
Braun powder; mp = 260°C. 
1H NMR (DMSO) δ: 9.04 (d, 1H, J = 6.6 Hz); 7.50 (d, 2H,              
J = 7.8 Hz); 7.32 (d, 2H, J = 7.8Hz); 7.20 (d, 1H, J = 6.6 Hz); 7.03 (s, 1H); 6.53 (s, 1H, H-5); 
4.10 (s, 3H, CH3-N
+); 3.30 (s, 3H, CH3-N rod); 2.50 (s, 3H, CH3-p-tolyl); 2.50 (s, 3H, CH3-
pyridine);  2.00  (s,  3H,  CH3-thiazol). 
13C  NMR  (DMSO)  δ:  163.2  (C=O);  161.2  (C=N
+);             
158.2 (C=N); 157.6 (C-2-thiazol); 154.2; 144.3; 142.6; 138.4; 132.5; 131.5; 129.8; 120.4; 
116.6;  105.3  (C-5-thiazol);  79.6  (C-5  rod);  43.2  (CH3-N
+);  30.2  (CH3-rod);  22.6  (CH3-p-
tolyl);  21.9  (CH3-pyridine);  14.9  (CH3-thiazol).  HRMS  (m/z):  found  423.1315  (calc.  for 
C22H23N4OS2, M
+requires: 423.1313). 
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